Uncovering Essential Insights on Stock SOLV

Shares of Health Care sector company Solventum moved 2.5% today, and are now trading at a price of $56.41. The Mid-Cap stock's daily volume was 1,527,010 compared to its average volume of 2,589,459. The S&P 500 index returned a -0.0% performance.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is based in Saint Paul and has 22,000 full time employees. Its market capitalization is $9,742,571,520.

4 analysts are following Solventum and have set target prices ranging from $54.0 to $70.0 per share. On average, they have given the company a rating of hold. At today's prices, SOLV is trading -14.21% away from its average analyst target price of $65.75 per share.

Over the last year, SOLV shares have gone down by -18.4%, which represents a difference of -41.6% when compared to the S&P 500. The stock's 52 week high is $72.4 per share and its 52 week low is $54.47.


The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.